Mon - Fri: 9:00am - 5:00pm

Fish oil Omega 3

Price
Ksh2299.00

Fish oil Omega3

Key Benefits

  • EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are the biologically active long-chain omega-3 fatty acids that the body cannot synthesize in adequate quantities from plant-based ALA alone — making supplementation critical for those with low oily fish intake.
  • DHA constitutes approximately 40% of the brain's polyunsaturated fatty acids and is the primary structural component of neural cell membranes. Adequate DHA is essential for maintaining membrane fluidity, synaptic transmission, and neuroplasticity — the biological basis of learning and memory.
  • EPA exerts powerful anti-inflammatory effects by competing with arachidonic acid (AA) for cyclooxygenase and lipoxygenase enzymes, thereby shifting eicosanoid production away from pro-inflammatory prostaglandins and leukotrienes toward anti-inflammatory resolvins and protectins.
  • Supports cardiovascular health by reducing serum triglyceride levels (by 20–50% at doses of 2–4g/day), improving endothelial function, reducing platelet aggregation, and lowering resting heart rate — collectively reducing the burden on the heart.
  • EPA plays a direct role in mood regulation by modulating serotonin receptor sensitivity, reducing neuroinflammation, and supporting neurotransmitter signaling, with substantial evidence for its role in managing depressive symptoms.
  • DHA supports retinal photoreceptor function — it is the dominant fatty acid in the photoreceptor outer segments of the eye — making omega-3 supplementation relevant for long-term eye health and protection against age-related macular degeneration.
  • The quick-release softgel format ensures rapid softgel dissolution in the gastrointestinal environment, improving bioavailability and reducing the fishy aftertaste common with cheaper, enteric-resistant formulations.

Recommended Usage

Scientific Backing

  • Triglyceride Reduction: A comprehensive meta-analysis in the Journal of the American Heart Association (Skulas-Ray et al., 2019) confirmed omega-3 fatty acids dose-dependently reduced triglycerides, with 4g/day producing 30% reductions — an effect endorsed by the FDA for prescription omega-3 therapy (Vascepa).
  • Brain Health: Research by Yurko-Mauro et al. (2010) in the journal Alzheimers & Dementia found DHA supplementation significantly improved learning and memory in adults with mild age-related cognitive decline.
  • Depression: A 2019 meta-analysis in Translational Psychiatry (Liao et al.) of 26 RCTs confirmed EPA-dominant fish oil had significant antidepressant effects comparable to low-dose antidepressants in mild-to-moderate depression.
  • Cardiovascular: The REDUCE-IT trial (NEJM, 2018) showed high-dose EPA (icosapentaenoic acid ethyl ester, 4g/day) reduced major cardiovascular events by 25% in patients with elevated triglycerides already on statins — a landmark finding.
  • Retinal Health: Studies in Investigative Ophthalmology and Visual Science confirm DHA supplementation slows progression of geographic atrophy in age-related macular degeneration and maintains photoreceptor integrity.